Published in Anesth Analg on November 10, 2011
Pharmacology and anti-addiction effects of the novel κ opioid receptor agonist Mesyl Sal B, a potent and long-acting analogue of salvinorin A. Br J Pharmacol (2014) 0.89
Salvinorin A administration after global cerebral hypoxia/ischemia preserves cerebrovascular autoregulation via kappa opioid receptor in piglets. PLoS One (2012) 0.86
Salvinorin A decreases mortality and improves neurological outcome in a neonatal mouse hypoxia model. Transl Perioper Pain Med (2014) 0.77
Kappa Opioid Receptor Agonist and Brain Ischemia. Transl Perioper Pain Med (2014) 0.77
The Role of κ Opioid Receptor in Brain Ischemia. Crit Care Med (2016) 0.76
Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist. Proc Natl Acad Sci U S A (2002) 4.34
Tissue plasminogen activator (tPA) increases neuronal damage after focal cerebral ischemia in wild-type and tPA-deficient mice. Nat Med (1998) 4.09
Models of white matter injury: comparison of infectious, hypoxic-ischemic, and excitotoxic insults. Ment Retard Dev Disabil Res Rev (2002) 2.00
Requirement for nitric oxide activation of p21(ras)/extracellular regulated kinase in neuronal ischemic preconditioning. Proc Natl Acad Sci U S A (2000) 1.60
Brain injury in the premature infant: overview of clinical aspects, neuropathology, and pathogenesis. Semin Pediatr Neurol (1998) 1.42
Nonproteolytic neuroprotection by human recombinant tissue plasminogen activator. Science (1999) 1.37
Isoflurane preconditions hippocampal neurons against oxygen-glucose deprivation: role of intracellular Ca2+ and mitogen-activated protein kinase signaling. Anesthesiology (2005) 1.36
Mitogen-activated protein kinases and cerebral ischemia. Mol Neurobiol (2001) 1.36
Anti-inflammatory and antinecrotic effects of the volatile anesthetic sevoflurane in kidney proximal tubule cells. Am J Physiol Renal Physiol (2006) 1.25
Salvinorin A: from natural product to human therapeutics. Mol Interv (2006) 1.19
Plasminogen activators contribute to impairment of hypercapnic and hypotensive cerebrovasodilation after cerebral hypoxia/ischemia in the newborn pig. Stroke (2005) 1.11
Potential anxiolytic- and antidepressant-like effects of salvinorin A, the main active ingredient of Salvia divinorum, in rodents. Br J Pharmacol (2009) 1.07
Activation of the extracellular signal-regulated protein kinase cascade in the hippocampal CA1 region in a rat model of global cerebral ischemic preconditioning. Neuroscience (1999) 1.04
Exercise preconditioning reduces neuronal apoptosis in stroke by up-regulating heat shock protein-70 (heat shock protein-72) and extracellular-signal-regulated-kinase 1/2. Neuroscience (2010) 1.02
Red blood cells-coupled tPA prevents impairment of cerebral vasodilatory responses and tissue injury in pediatric cerebral hypoxia/ischemia through inhibition of ERK MAPK activation. J Cereb Blood Flow Metab (2009) 1.02
Salvinorin A: a novel and highly selective kappa-opioid receptor agonist. Life Sci (2004) 0.95
Ischemic preconditioning-induced activation of ERK1/2 in the rat hippocampus. Neurosci Lett (2006) 0.94
Salvinorin A produces cerebrovasodilation through activation of nitric oxide synthase, κ receptor, and adenosine triphosphate-sensitive potassium channel. Anesthesiology (2011) 0.93
NOC/oFQ and NMDA contribute to piglet hypoxic ischemic hypotensive cerebrovasodilation impairment. Pediatr Res (2002) 0.88
Mu and kappa opioids modulate mouse embryonic stem cell-derived neural progenitor differentiation via MAP kinases. J Neurochem (2009) 0.86
Extracellular signal-regulated kinase and c-Jun N-terminal protein kinase in ischemic tolerance. Neuroreport (2001) 0.86
The effect of the kappa-opioid receptor agonist CI-977 in a rat model of focal cerebral ischaemia. Brain Res (1992) 0.84
Dynorphin(1-13) improves survival in cats with focal cerebral ischaemia. Nature (1985) 0.83
Contribution of kca channel activation to hypoxic cerebrovasodilation does not involve NO. Brain Res (1998) 0.81
Surrogate markers for neurological outcome in children after deep hypothermic circulatory arrest. Semin Cardiothorac Vasc Anesth (2007) 0.81
New approaches to neuroprotection in infant heart surgery. Pediatr Res (2010) 0.81
Signaling events initiated by kappa opioid receptor activation: quantification and immunocolocalization using phospho-selective KOR, p38 MAPK, and K(IR) 3.1 antibodies. Methods Mol Biol (2011) 0.80
Role of cAMP and K(+) channel-dependent mechanisms in piglet hypoxic/ischemic impaired nociceptin/orphanin FQ-induced cerebrovasodilation. Brain Res (2000) 0.79
Altered release of prostaglandins contributes to hypoxic/ischemic impairment of NOC/oFQ cerebrovasodilation. Brain Res (2000) 0.77
Inhibition of nitric oxide synthesis following severe hypoxia-ischemia restores autoregulation of cerebral blood flow in newborn lambs. Early Hum Dev (2001) 0.77
Detection of genotyping errors by Hardy-Weinberg equilibrium testing. Eur J Hum Genet (2004) 2.65
Airway trauma in a high patient volume academic cardiac electrophysiology laboratory center. Anesth Analg (2012) 2.06
A unitary anesthetic binding site at high resolution. J Biol Chem (2009) 1.34
Case report: Anti-N-methyl-D-aspartate receptor encephalitis and its anesthetic implications. Anesth Analg (2011) 1.25
Cerebral hemodynamic predictors of poor 6-month Glasgow Outcome Score in severe pediatric traumatic brain injury. J Neurotrauma (2009) 1.22
Young age as a risk factor for impaired cerebral autoregulation after moderate to severe pediatric traumatic brain injury. Anesthesiology (2008) 1.21
Comparison of common gamma-chain cytokines, interleukin-2, interleukin-7, and interleukin-15 for the in vitro generation of human tumor-reactive T lymphocytes for adoptive cell transfer therapy. J Immunother (2006) 1.19
Identification of a psoriasis susceptibility candidate gene by linkage disequilibrium mapping with a localized single nucleotide polymorphism map. Genomics (2002) 1.12
Dopamine prevents impairment of autoregulation after traumatic brain injury in the newborn pig through inhibition of Up-regulation of endothelin-1 and extracellular signal-regulated kinase mitogen-activated protein kinase. Pediatr Crit Care Med (2013) 1.10
Inhalational anesthetic-binding proteins in rat neuronal membranes. J Biol Chem (2004) 1.08
Cerebral blood flow and autoregulation after pediatric traumatic brain injury. Pediatr Neurol (2008) 1.06
Identification of a novel asthma susceptibility gene on chromosome 1qter and its functional evaluation. Hum Mol Genet (2008) 1.05
tPA contributes to impaired NMDA cerebrovasodilation after traumatic brain injury through activation of JNK MAPK. Neurol Res (2011) 1.01
Signaling, delivery and age as emerging issues in the benefit/risk ratio outcome of tPA For treatment of CNS ischemic disorders. J Neurochem (2010) 0.98
Presentation of tumor antigens by dendritic cells genetically modified with viral and nonviral vectors. J Immunother (2006) 0.96
The brain tumor window model: a combined cranial window and implanted glioma model for evaluating intraoperative contrast agents. Neurosurgery (2010) 0.95
Preferential Protection of Cerebral Autoregulation and Reduction of Hippocampal Necrosis With Norepinephrine After Traumatic Brain Injury in Female Piglets. Pediatr Crit Care Med (2016) 0.95
Differential role of PTK and ERK MAPK in superoxide impairment of K(ATP) and K(Ca) channel cerebrovasodilation. Am J Physiol Regul Integr Comp Physiol (2003) 0.94
Photoactive analogues of the haloether anesthetics provide high-resolution features from low-affinity interactions. ACS Chem Biol (2006) 0.93
Salvinorin A produces cerebrovasodilation through activation of nitric oxide synthase, κ receptor, and adenosine triphosphate-sensitive potassium channel. Anesthesiology (2011) 0.93
TBI sex dependently upregulates ET-1 to impair autoregulation, which is aggravated by phenylephrine in males but is abrogated in females. J Neurotrauma (2012) 0.90
PTK, MAPK, and NOC/oFQ impair hypercapnic cerebrovasodilation after hypoxia/ischemia. Am J Physiol Heart Circ Physiol (2003) 0.89
Relationship between NOC/oFQ, dynorphin, and COX-2 activation in impaired NMDA cerebrovasodilation after brain injury. J Neurotrauma (2002) 0.89
A computationally designed water-soluble variant of a G-protein-coupled receptor: the human mu opioid receptor. PLoS One (2013) 0.88
tPA-S481A prevents neurotoxicity of endogenous tPA in traumatic brain injury. J Neurotrauma (2012) 0.87
Development of a fluorescent microsphere technique for rapid histological determination of cerebral blood flow. Brain Res (2010) 0.87
Salvinorin A administration after global cerebral hypoxia/ischemia preserves cerebrovascular autoregulation via kappa opioid receptor in piglets. PLoS One (2012) 0.86
Novel plasminogen activator inhibitor-1-derived peptide protects against impairment of cerebrovasodilation after photothrombosis through inhibition of JNK MAPK. Am J Physiol Regul Integr Comp Physiol (2010) 0.85
Scalable production of highly sensitive nanosensors based on graphene functionalized with a designed G protein-coupled receptor. Nano Lett (2014) 0.85
PAI-1-derived peptide EEIIMD prevents impairment of cerebrovasodilation by augmenting p38 MAPK upregulation after cerebral hypoxia/ischemia. Am J Physiol Heart Circ Physiol (2010) 0.84
NMDA dilates pial arteries by KATP and Kca channel activation. Brain Res Bull (2004) 0.84
Ferritin couples iron and fatty acid metabolism. FASEB J (2012) 0.83
tPA contributes to impairment of ATP and Ca sensitive K channel mediated cerebrovasodilation after hypoxia/ischemia through upregulation of ERK MAPK. Brain Res (2010) 0.82
Upper extremity deep vein thrombosis in a patient treated for malignant hyperthermia. J Clin Anesth (2013) 0.82
Characterization of a computationally designed water-soluble human μ-opioid receptor variant using available structural information. Anesthesiology (2014) 0.82
Inhibition of integrin alphavbeta3 prevents urokinase plasminogen activator-mediated impairment of cerebrovasodilation after cerebral hypoxia/ischemia. Am J Physiol Heart Circ Physiol (2009) 0.82
Selective blockade of AT1 receptor attenuates impairment of hypotensive autoregulation and improves cerebral blood flow after brain injury in the newborn pig. Anesthesiology (2003) 0.81
Identification and characterization of a tumor infiltrating CD56(+)/CD16 (-) NK cell subset with specificity for pancreatic and prostate cancer cell lines. Cancer Immunol Immunother (2010) 0.81
Red blood cell-coupled tissue plasminogen activator prevents impairment of cerebral vasodilatory responses through inhibition of c-Jun-N-terminal kinase and potentiation of p38 mitogen-activated protein kinase after cerebral photothrombosis in the newborn pig. Pediatr Crit Care Med (2011) 0.81
Nitric oxide contributes to AT2 but not AT1 angiotensin II receptor-mediated vasodilatation of porcine pial arteries and arterioles. Eur J Pharmacol (2005) 0.81
Dynamics of Elective Case Cancellation for Inpatient and Outpatient in an Academic Center. J Anesth Clin Res (2013) 0.81
NOC/oFQ activates ERK and JNK but not p38 MAPK to impair prostaglandin cerebrovasodilation after brain injury. Brain Res (2005) 0.80
Predictors of breast and cervical cancer screening among Chamorro women in Southern California. J Cancer Educ (2010) 0.80
The effect of chronic phenytoin administration on single prolonged stress induced extinction retention deficits and glucocorticoid upregulation in the rat medial prefrontal cortex. Psychopharmacology (Berl) (2014) 0.80
Ligand interaction, binding site and G protein activation of the mu opioid receptor. Eur J Pharmacol (2013) 0.79
Herkinorin dilates cerebral vessels via kappa opioid receptor and cyclic adenosine monophosphate (cAMP) in a piglet model. Brain Res (2012) 0.79
Memory Loss, Alzheimer's Disease and General Anesthesia: A Preoperative Concern. J Anesth Clin Res (2012) 0.79
Analysis of chloroformate-derivatised amino acids, dipeptides and polyamines by LC-MS/MS. J Chromatogr B Analyt Technol Biomed Life Sci (2013) 0.78
Endothelin-1 concentrations in clone calves, their surrogate dams, and fetal fluids at birth: association with oxygen treatment. J Vet Intern Med (2005) 0.78
tPA-S(481)A prevents impairment of cerebrovascular autoregulation by endogenous tPA after traumatic brain injury by upregulating p38 MAPK and inhibiting ET-1. J Neurotrauma (2013) 0.78
Influence of Sex and ERK MAPK on the Pressure Reactivity Index in Newborn Piglets After Fluid Percussion Injury. Transl Stroke Res (2012) 0.77
Recognition of anesthetic barbiturates by a protein binding site: a high resolution structural analysis. PLoS One (2012) 0.77
Differential role of PTK, ERK and p38 MAPK in superoxide impairment of NMDA cerebrovasodilation. Brain Res (2003) 0.77
Perioperative Pain Management for Patients on Chronic Buprenorphine: A Case Report. J Anesth Clin Res (2013) 0.77
Nociceptin/orphanin FQ alters prostaglandin cerebrovascular action following brain injury. J Neurotrauma (2004) 0.77
The Role of κ Opioid Receptor in Brain Ischemia. Crit Care Med (2016) 0.76
Prostaglandins contribute to impaired angiotensin II-induced cerebral vasodilation after brain injury. J Neurotrauma (2002) 0.76
Newborn pig nociceptin/orphanin FQ activates protein tyrosine kinase and mitogen activated protein kinase to impair NMDA cerebrovasodilation after ischemia. Neuroreport (2003) 0.76
Molecular interactions between general anesthetics and the 5HT2B receptor. J Biomol Struct Dyn (2013) 0.76
An ICU Preanesthesia Evaluation Form Reduces Missing Preoperative Key Information. J Anesth Clin Res (2012) 0.75
PAI-1-derived peptide EEIIMD prevents hypoxia/ischemia-induced aggravation of endothelin- and thromboxane-induced cerebrovasoconstriction. Neurocrit Care (2014) 0.75
In response. Anesth Analg (2013) 0.75
Hypoxia Induces Internalization of κ-Opioid Receptor. Anesthesiology (2017) 0.75
RBC-coupled tPA Prevents Whereas tPA Aggravates JNK MAPK-Mediated Impairment of ATP- and Ca-Sensitive K Channel-Mediated Cerebrovasodilation After Cerebral Photothrombosis. Transl Stroke Res (2012) 0.75
Opioid binding sites in human serum albumin. Anesth Analg (2011) 0.75
Precautions for Intubating Patients with COVID-19. Anesthesiology (2020) 0.75
n-Dodecyl β-D-maltoside specifically competes with general anesthetics for anesthetic binding sites. J Biomol Struct Dyn (2013) 0.75
The evaluation and treatment of prostate-related LUTS in the primary care setting: the next STEP. Curr Urol Rep (2013) 0.75
Chronic Opioid Usage in Surgical Patients in a Large Academic Center. Ann Surg (2017) 0.75
Retracted Clazosentan, a novel endothelin A antagonist, improves cerebral blood flow and behavior after traumatic brain injury. Neurol Res (2011) 0.75